Cibiem Obtains $10,000,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c82a78c-9fcc-4d5c-92e9-b847b87f73d1&Preview=1 -
Date
10/18/2012 -
Company Name
Cibiem -
Mailing Address
134 West 26th Street New York, NY 10001 -
Company Description
Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. -
Website
http://www.cibiem.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Cibiem is launching out of the medical device incubator Coridea, and will use the money to develop its catheter-based treatment of diseases such as hypertension, heart failure, diabetes and renal failure. -
M&A Terms
-
Venture Investor
SV Life Sciences -
Venture Investor
Third Rock Ventures
